相关实验视频
Updated: Jul 12, 2025

04:41
Knee Arthrocentesis in Adults
Published on: February 25, 2022
7.6K
在全膝关节关节整形手术中使用基于血的血静剂的影响:元分析
Jung-Wee Park1,2, Tae Woo Kim2,3, Chong Bum Chang1,2
1Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea.
Journal of clinical medicine
|October 28, 2023
概括
基于血栓激素的血静矩阵Floseal有效地减少了在全膝关节整形术 (TKA) 中的血液损失和输血需求. 这一元分析证实了其在尽量减少血红蛋白下降方面的好处,以及对全基输血的要求.
科学领域:
- 整形外科手术 整形外科手术
- 血液学 血液学 血液学
- 生物材料是一种生物材料.
背景情况:
- 在全膝关节整形术 (TKA) 中,尽量减少血液损失和输血需求对于患者的治疗结果至关重要.
- 在TKA中,像Floseal这样的止血药的疗效正在进行调查.
- 基于凝血素的静血矩阵旨在改善外科手术的静血.
研究的目的:
- 通过对随机对照试验 (RCT) 的元分析,评估Floseal在TKA中的有效性和安全性.
- 综合目前关于Floseal对血液流失和输血率的影响的证据.
- 提供Floseal在TKA程序中的作用的最新评估.
主要方法:
- 在电子数据库中进行了系统的文献搜索,以确定相关的RCT.
- 对包括的研究进行了方法质量评估和数据提取.
- 血红蛋白下降和输血风险的聚合效应大小是使用标准化平均差异 (SMD) 和几率比率 (OR) 计算的,其中有95%的置信区间 (CI).
主要成果:
- 八个涉及904名患者的RCT被纳入了分析.
- 叶片剂显著降低了血红蛋白下降 (SMD = -0.49) 和异构输血的风险 (OR = 0.45).
- 没有观察到排水量或总血液损失的显著差异;没有检测到出版偏差.
结论:
- 这一元分析提供了强有力的证据,表明Floseal有效地减少了TKA中的血红蛋白下降和输血需求.
- 在全膝关节整形术期间,Floseal在控制血液损失和输血需求方面显示出显著的好处.
- 建议进行进一步的精心设计的随访期长期的RCT,以确定长期的疗效和安全性.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
723
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
723
Extrinsic and Intrinsic Pathways of Hemostasis
8.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.0K
Clot Retraction and Fibrinolysis
6.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.3K
Introduction to Hemostasis
8.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.1K

